Integrative Cancer Epidemiology Programme 2
The health economics component of this major programme of research on cancer epidemiology will develop new causal evidence on the effect of cancers on healthcare cost and on health-related quality of life. The work will also explore the potential for genetic data to influence the cost-effectiveness of screening programmes.
Oxford project lead:
-
Padraig Dixon
Senior Researcher in Health Economics
Collaborators:
Richard Martin, University of Bristol
Dates:
2020 – 2025
Funder:
Cancer Research UK
-
Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review
Journal article
TAYLOR J. et al, (2022), Genetics in Medicine
Our team
-
Stavros Petrou
Academic Research Lead in Health Economics
-
Carmen Fierro Martinez
NIHR Pre-Doctoral Fellow
-
Catia Nicodemo
Senior Research Fellow in Health Economics
-
Corneliu Bolbocean
Senior Researcher in Health Economics
-
Elizabeth-Ann Schroeder
Senior Researcher in Health Economics
-
Felix Achana
Senior Researcher in Health Economics
-
Joan Madia
Researcher in Health Economics
-
Joaquim Vidiella Martin
Researcher in Economics
-
John Buckell
Researcher
-
Joseph Kwon
Researcher in Health Economics
-
Laia Bosque Mercader
Research Fellow in Health Economics
-
Laura Armitage
Wellcome Trust Doctoral Research Fellow
-
Lucy Abel
Health Economist, DPhil student
-
May Png
Senior Researcher in Health Economics
-
Nadeem Hussein
NIHR Pre-Doctoral Fellow
-
Olu Onyimadu
Health Economist, DPhil Candidate
-
Padraig Dixon
Senior Researcher in Health Economics
-
Patrick Fahr
Quantitative Researcher
-
Raphael Wittenberg
Deputy Director, Centre for Health Service Economics and Organisation
-
Stuart Redding
Project Lead, Centre for Health Service Economics & Organisation
-
Sungwook Kim
Senior researcher in Health Economics
-
Yaling Yang
Senior Researcher in Health Economics